Jasper Therapeutics Director Kurt von Emster Receives Option Award

What Happened

• Kurt von Emster, a non-employee director of Jasper Therapeutics (JSPR), was granted a derivative award on 2026-07-31: an option to purchase 7,500 shares. The Form 4 reports the transaction price as $0.00 (grant reported as an award/derivative). The Form 4 covering this transaction was filed on 2026-08-04.

Key Details

• Transaction date: 2026-07-31; Form 4 filed: 2026-08-04
• Security: Option/derivative to purchase 7,500 shares; reported price: $0.00
• Shares owned after transaction: Not specified in the filing
• Footnote: Grant was made automatically under the Issuer's Non-Employee Director Compensation Policy; the option vests in full on the first anniversary of the grant, subject to continued service
• Filing timeliness: No late-filing flag indicated in the provided data

Context

• This is a routine, compensation-related option grant for a non-employee director (not an open-market purchase or sale). Such awards are common for director compensation and do not by themselves indicate insider sentiment about the company's stock. The option vests after one year of continued service; further disclosures (e.g., if the option is exercised or shares are sold) would appear in future filings.